Specialty Generics Market Growth, Demand and Challenges of the Key Industry Players 2032

1
Global Specialty Generics Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Specialty Generics Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global specialty
  generics market size reached US 74.7 Billion in
  2023.
• Specialty generics refer to off-patented drugs
  which are used to target chronic or complex
  health conditions. These drugs require special
  handling, monitoring or administration and
  generally need prior authorization to order them.
  Nowadays, specialty generics are gaining immense
  popularity as they are utilized to treat rare
  chronic diseases such as cancer, HIV AIDS,
  rheumatoid arthritis and hemophilia.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/specialty-generics-mark
  et/requestsample

4
Report Description

• Global Specialty Generics Market Trends
• The increasing demand for specialty drugs has
  encouraged the governments of various countries
  to regulate and provide supporting policies for
  the production of specialty generics. Besides
  this, unlike newly patented specialty drugs,
  specialty generics are less expensive to develop
  and manufacture as they do not have to undergo
  any clinical trials and approval before entering
  the market. As a result, these products involve
  low risk and high margins as compared to newly
  patented drugs which usually take three to four
  years for product development and approval.
• Moreover, manufacturers are involved in research
  and development (RD) to create new and
  innovative specialty drug formulations that are
  more efficient and cost-effective as compared to
  their branded counterparts. Additionally, several
  companies are engaging in mergers and
  acquisitions (MA) to expand their specialty
  generics capacities. For instance, Alvogen, a
  pharmaceutical company, acquired County Line
  Pharmaceuticals that is involved in the
  development of specialty generics.
• Looking forward, the market value is projected to
  reach US 172.5 Billion by 2032, exhibiting a
  CAGR of 9.4 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/specialty-generics-mark
  et

5
Report Segmentation

• Breakup by Route of Administration
• Injectables
• Oral
• Others
•  
• Breakup by Indication
• Oncology
• Autoimmune Diseases
• Infectious Diseases
• Others
• Breakup by Distribution channel
• Retail Pharmacies
• Specialty Pharmacies

6
Report Segmentation

• Hospital Pharmacies
• Breakup by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Teva Pharmaceuticals Industries
• Akorn, Inc.
• Mylan N.V.
• Mallinckrodt
• Sandoz International GmbH
• Pfizer, Inc.
• Sun Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals
• Apotex Corp.
• Endo International plc

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4 Global
  Specialty Generics Market Introduction
• 5 Why are Specialty Generics So Lucrative?
• 6 Global Specialty Generics Market
• 6.1 Market Overview
• 6.2 Market Performance
• 6.3 Impact of COVID-19
• 6.4 Market Breakup by Route of
  Administration
• 6.5 Market Breakup by Indication
• 6.6 Market Breakup by Distribution Channel
• 6.7 Market Breakup by Region
• 6.8 Market Forecast
• 6.9 SWOT Analysis
•         6.9.1    Overview        6.9.2  
   Strengths        6.9.3    Weaknesses       
  6.9.4    Opportunities        6.9.5  
   Threats       

10
Table of Contents

• 6.10 Value Chain Analysis
• 6.11 Porters Five Forces Analysis
• 6.11.1 Overview
• 6.11.2 Bargaining Power of Buyers
• 6.11.3 Bargaining Power of Suppliers
• 6.11.4 Degree of Competition
• 6.11.5 Threat of New Entrants
• 6.11.6 Threat of Substitutes
• 6.12 Key Market Drivers and Success
  Factors
• 7 Market Breakup by Route of Administration
• 7.1 Injectable
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Oral
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Others
• 7.3.1 Market Trends
• 7.3.2 Market Forecast

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com